UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The odd sibling: features of β3-adrenoceptor pharmacology

Molecular pharmacology, 2014-11, Vol.86 (5), p.479-484

2014

Volltextzugriff (PDF)

Cyclin-Dependent Kinase 18 Controls Trafficking of Aquaporin-2 and Its Abundance through Ubiquitin Ligase STUB1, Which Functions as an AKAP

Cells (Basel, Switzerland), 2020-03, Vol.9 (3), p.673

2020

Volltextzugriff (PDF)

TRPM2 Plays a Minor Role in AKI and Kidney Fibrosis

Kidney360, 2022-01, Vol.3 (1), p.153-157

2022

Volltextzugriff (PDF)

Specificity evaluation of antibodies against human β3-adrenoceptors

Naunyn-Schmiedeberg's archives of pharmacology, 2012-09, Vol.385 (9), p.875-882

2012

Volltextzugriff (PDF)

β3-Adrenoceptor-mediated relaxation of rat and human urinary bladder: roles of BKCa channels and Rho kinase

Naunyn-Schmiedeberg's archives of pharmacology, 2015-07, Vol.388 (7), p.749-759

2015

Volltextzugriff (PDF)

Rat β3-adrenoceptor protein expression: antibody validation and distribution in rat gastrointestinal and urogenital tissues

Naunyn-Schmiedeberg's archives of pharmacology, 2014-11, Vol.387 (11), p.1117-1127

2014

Volltextzugriff (PDF)

Revealing the Antifibrotic Mechanism of Finerenone in the DOCA-Salt Nephropathy Rat Model Using Single Nuclei and Bulk Transcriptomics: PO2521

Journal of the American Society of Nephrology, 2021-10, Vol.32 (10S), p.765-765

2021

Volltextzugriff (PDF)

Uncovering Genomic Alterations in DOCA-Salt Nephropathy Rats Treated with Finerenone: PO0623

Journal of the American Society of Nephrology, 2020-10, Vol.31 (10S), p.238-238

2020

Volltextzugriff (PDF)

The Novel Potent and Selective Vasopressin V1a Antagonist BAY2327949 Blocks Arginine Vasopressin-Mediated Decline of Renal Blood Flow and Tissue Oxygenation: PO0647

Journal of the American Society of Nephrology, 2020-10, Vol.31 (10S), p.245-245

2020

Volltextzugriff (PDF)

Kidney Functional Improvements by a Novel Potent and Selective Vasopressin V1a Antagonist After Ischemia/Reperfusion Injury (I/RI) in Rats: PO0164

Journal of the American Society of Nephrology, 2020-10, Vol.31 (10S), p.106-106

2020

Volltextzugriff (PDF)

Ramipril restores PPARβ/δ and PPARγ expressions and reduces cardiac NADPH oxidase but fails to restore cardiac function and accompanied myosin heavy chain ratio shift in severe anthracycline-induced cardiomyopathy in rat

European journal of pharmacology, 2016-11, Vol.791, p.244-253

2016

Volltextzugriff (PDF)

Single-cell transcriptomics and chromatin accessibility profiling elucidate the kidney-protective mechanism of mineralocorticoid receptor antagonists

The Journal of clinical investigation, 2024-01, Vol.134 (1), p.1-18

2024

Volltextzugriff (PDF)

The Odd Sibling: Features of β 3 -Adrenoceptor Pharmacology

Molecular pharmacology, 2014-11, Vol.86 (5), p.479-484

2014

Volltextzugriff (PDF)

Activation of CD8 + T Cells in Chronic Obstructive Pulmonary Disease Lung

American journal of respiratory and critical care medicine, 2023-12, Vol.208 (11), p.1177-1195

2023

Volltextzugriff (PDF)

The pharmacological rationale for combining muscarinic receptor antagonists and β-adrenoceptor agonists in the treatment of airway and bladder disease

Current opinion in pharmacology, 2014-06, Vol.16 (100), p.31-42

2014

Volltextzugriff (PDF)

Desirable properties of β₃-adrenoceptor agonists: Implications for the selection of drug development candidates

European journal of pharmacology, 2011-04, Vol.657 (1-3), p.1-3

2011

Volltextzugriff (PDF)

Enalaprilat increases PPARβ/δ expression, without influence on PPARα and PPARγ, and modulate cardiac function in sub-acute model of daunorubicin-induced cardiomyopathy

European journal of pharmacology, 2013-08, Vol.714 (1-3), p.472-477

2013

Volltextzugriff (PDF)

Desirable properties of β 3-adrenoceptor agonists: Implications for the selection of drug development candidates

European journal of pharmacology, 2011, Vol.657 (1), p.1-3

2011

Volltextzugriff (PDF)

Selective inhibitory action of Biginelli-type dihydropyrimidines on depolarization-induced arterial smooth muscle contraction

Journal of pharmacy and pharmacology, 2012-05, Vol.64 (5), p.735-741

2012

Volltextzugriff (PDF)

Pioglitazone, a PPARγ agonist, provides comparable protection to angiotensin converting enzyme inhibitor ramipril against adriamycin nephropathy in rat

European journal of pharmacology, 2014-05, Vol.730, p.51-60

2014

Volltextzugriff (PDF)

[beta]^sub 3^-Adrenoceptor-mediated relaxation of rat and human urinary bladder: roles of BK^sub Ca^ channels and Rho kinase

Naunyn-Schmiedeberg's archives of pharmacology, 2015-07, Vol.388 (7), p.749

2015

Volltextzugriff (PDF)

Follistatin‐like 1 enhances cigarette smoke‐induced interleukin‐8 secretion from human airway smooth muscle cells

The FASEB journal, 2013-04, Vol.27 (S1)

2013

Volltextzugriff (PDF)

Erratum to: Rat β3-adrenoceptor protein expression: antibody validation and distribution in rat gastrointestinal and urogenital tissues

Naunyn-Schmiedeberg's archives of pharmacology, 2014-11, Vol.387 (11), p.1129-1129

2014

Volltextzugriff (PDF)

Glucose and blood pressure lowering effects of Pycnogenol® are inefficient to prevent prolongation of QT interval in experimental diabetic cardiomyopathy

Pathology, research and practice, 2012-08, Vol.208 (8), p.452-457

2012

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)

Erscheinungsjahr

n.n

Thema

Animals
(14)
Life Sciences & Biomedicine
(10)
Science & Technology
(10)
Humans
(9)
Rats
(7)
Rats, Wistar
(7)
Male
(6)
Pharmacology & Pharmacy
(5)
Biomedical And Life Sciences
(4)
Biomedicine
(4)
Gene Expression Regulation - Drug Effects
(4)
Neurosciences
(4)
Pharmacology/toxicology
(4)
Adrenergic Beta-3 Receptor Agonists - Pharmacology
(3)
Mice
(3)
Receptors, Adrenergic, Beta-3 - Genetics
(3)
Receptors, Adrenergic, Beta-3 - Metabolism
(3)
Selectivity
(3)
Adrenergic Receptors
(2)
Adrenoceptors
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The odd sibling: features of β3-adrenoceptor pharmacology

Cyclin-Dependent Kinase 18 Controls Trafficking of Aquaporin-2 and Its Abundance through Ubiquitin Ligase STUB1, Which Functions as an AKAP

TRPM2 Plays a Minor Role in AKI and Kidney Fibrosis

Specificity evaluation of antibodies against human β3-adrenoceptors

β3-Adrenoceptor-mediated relaxation of rat and human urinary bladder: roles of BKCa channels and Rho kinase

Rat β3-adrenoceptor protein expression: antibody validation and distribution in rat gastrointestinal and urogenital tissues

Revealing the Antifibrotic Mechanism of Finerenone in the DOCA-Salt Nephropathy Rat Model Using Single Nuclei and Bulk Transcriptomics: PO2521

Uncovering Genomic Alterations in DOCA-Salt Nephropathy Rats Treated with Finerenone: PO0623

The Novel Potent and Selective Vasopressin V1a Antagonist BAY2327949 Blocks Arginine Vasopressin-Mediated Decline of Renal Blood Flow and Tissue Oxygenation: PO0647

Kidney Functional Improvements by a Novel Potent and Selective Vasopressin V1a Antagonist After Ischemia/Reperfusion Injury (I/RI) in Rats: PO0164

Ramipril restores PPARβ/δ and PPARγ expressions and reduces cardiac NADPH oxidase but fails to restore cardiac function and accompanied myosin heavy chain ratio shift in severe anthracycline-induced cardiomyopathy in rat

Single-cell transcriptomics and chromatin accessibility profiling elucidate the kidney-protective mechanism of mineralocorticoid receptor antagonists

The Odd Sibling: Features of β 3 -Adrenoceptor Pharmacology

Activation of CD8 + T Cells in Chronic Obstructive Pulmonary Disease Lung

The pharmacological rationale for combining muscarinic receptor antagonists and β-adrenoceptor agonists in the treatment of airway and bladder disease

Desirable properties of β₃-adrenoceptor agonists: Implications for the selection of drug development candidates

Enalaprilat increases PPARβ/δ expression, without influence on PPARα and PPARγ, and modulate cardiac function in sub-acute model of daunorubicin-induced cardiomyopathy

Desirable properties of β 3-adrenoceptor agonists: Implications for the selection of drug development candidates

Selective inhibitory action of Biginelli-type dihydropyrimidines on depolarization-induced arterial smooth muscle contraction

Pioglitazone, a PPARγ agonist, provides comparable protection to angiotensin converting enzyme inhibitor ramipril against adriamycin nephropathy in rat

[beta]^sub 3^-Adrenoceptor-mediated relaxation of rat and human urinary bladder: roles of BK^sub Ca^ channels and Rho kinase

Follistatin‐like 1 enhances cigarette smoke‐induced interleukin‐8 secretion from human airway smooth muscle cells

Erratum to: Rat β3-adrenoceptor protein expression: antibody validation and distribution in rat gastrointestinal and urogenital tissues

Glucose and blood pressure lowering effects of Pycnogenol® are inefficient to prevent prolongation of QT interval in experimental diabetic cardiomyopathy

Suchergebnisse filtern